abstract |
The present invetion is directed to the citrate salt of 5, 8, 14-triazatetracyclo[10.3.1.0?2.11.04.9¿]-hexadeca-2(11),3,5,7,9-pentaene, formula 1, and pharmaceutical compositions thereof. The presetn invention is also directed to the various forms fo the citrate salt, particularly its hydrate and its anhydrous/nearly anyhydrous polmorph. The invention is also directed to processes for preparation of these citrate salt forms. |